This chapter works out how calories and dietary fat actually move body composition: why a surplus permits muscle growth but cannot command it, how big that surplus should be, when muscle gain and fat loss can happen at once, and where the fat floor sits on a cut. It then turns from amount to type — the evidence against the seed-oil villain narrative, the thin-but-real mechanistic case for omega-3 in muscle — and closes on the supplement category sold as a shortcut past all of it, over-the-counter testosterone boosters. The through-line is that most of the leverage sits in training and total intake, and that the claims promising otherwise mostly fail on evidence quality.
The foundation for everything else in this chapter is a claim about causal roles: nutrition plays a permissive, not causative, role in muscle building. Training is the signal that tells muscle to grow — see Resistance Training & Performance Supplements for what actually constitutes that signal — while diet only supplies the raw material. The practical consequence is unintuitive to anyone who has been told to "eat big to get big": aggressive overfeeding cannot force muscle growth beyond what the training stimulus calls for. Past that ceiling, the extra food primarily becomes fat, even with a training stimulus in place.
The controlled evidence is Garth et al. (2013): 47 elite athletes over 10 weeks, where the large-surplus group ate 621 more calories per day than the small-surplus group. They gained more total weight and much more fat, with only a non-significant edge in lean mass. A 2019 study corroborated the finding. That is the empirical core of the case against dirty bulking — not that a surplus is unnecessary, but that its size has sharply diminishing returns on the part you actually want.
What falls out of this is a menu rather than a single number. A 10–20% surplus is the "dreamer bulk" range: faster gains, and comfort with the fat that comes along. A 5–10% surplus is the leaner bulk — slower gains, less fat accumulation. And a slight caloric deficit is the option for prioritizing fat loss while still building some muscle, which is the territory of Body Recomposition (Recomp) Without a Caloric Deficit. Protein targets shift between these states, and Protein & Muscle-Building Nutrition covers how.
The honest complication comes from coaching rather than a trial. Despite Garth showing no statistically significant extra lean mass from the large surplus, Jeff Nippard's experience is that aggressive dreamer bulks can still produce more long-term strength gain and let a lifter occupy more total mass — while making the eventual cut harder, and usually not being worth it for most people. That is anecdote layered on top of the RCT evidence, not replacing it, and the discipline for holding those two things in the right order is the subject of Evaluating Evidence & Supplement Quality.
Body recomposition — simultaneous muscle gain and fat loss — is often treated as a beginner-only fluke. The material here says otherwise, and further, that it does not require a caloric deficit. At least a dozen studies demonstrate recomposition, and in 7 of 10 reviewed studies lean-mass gain outpaced fat gain even in a caloric surplus (Alan Aragon, "How to Lose Fat & Gain Muscle With Nutrition"). The protocol attached to that claim is specific: resistance training 3x/week, cardio 3x/week for roughly an hour and mostly in zone two, and a "judicious" ~10% caloric surplus of 200–300 calories sourced largely from quality protein — the low end of the ranges in the previous section, deliberately.
A stranger result sits alongside it. Very high protein intake on its own — 1–2 g per pound, added on top of the habitual diet with exercise unchanged — reliably triggers spontaneous fat loss or recomposition across roughly five free-living studies (Jose Antonio). The apparent mechanism is that the protein suppresses intake of the other macronutrients while raising energy expenditure; one 2 g/lb, 8-week protocol produced subjects reporting they were "sweating while sleeping." Protein & Muscle-Building Nutrition covers where those targets come from in the first place.
Then the boundary case that keeps this from being a clean rule. A metabolic-ward study by Bray removed exercise entirely and simply escalated protein and calories — and produced gains in both fat and lean mass, the opposite of the free-living result. The reading offered here is that the recomposition effect depends on the combination of resistance training plus a free-living protein surplus, not on high protein alone. It also lands squarely on the metabolic-ward-versus-free-living reliability tension discussed in Evaluating Evidence & Supplement Quality: the tightly controlled study and the messier realistic one disagree, and which one you privilege changes the advice.
One measurement trap is worth carrying out of this section. Net body-mass gain across a recomposition period can coexist with fat being lost the entire time. If you are watching only the scale number rather than the composition breakdown, the protocol that is working will look like the protocol that is failing.
When calories come down, fat is usually the macronutrient people cut first — it is calorie-dense and, unlike protein, has no obvious muscle-retention story attached. The recommendation here is a hard floor: 15–20% of total calories from fat, roughly 40–60 g/day on a typical contest-prep calorie target.
The reason is not macro-split preference. Lower fat intakes have been associated with reductions in testosterone, which works against both general health and muscle retention while dieting — precisely when muscle retention is the whole point. The cited real-world miss makes the shape of the error clear: a contest-prep plan that hit 265 g of protein (a target Protein & Muscle-Building Nutrition would call generous) while getting only 13% of calories from fat. It was flagged as "particularly concerning" because of the testosterone link, not because fat itself was thought dangerous. The same hormonal lever gets targeted from the supplement side in Testosterone Boosters (OTC Supplements), with considerably worse results.
Note that this is a floor on amount, and it is fully separable from the fat-type question — saturated versus unsaturated, seed oils versus animal fats — taken up in Seed Oils vs. Animal Fats: Cardiovascular Evidence. A diet can get the type entirely right and still fail this minimum.
Worth saying plainly: this is the only cutting parameter the chapter's material specifies. There is no guidance here on how large a deficit should be, how fast weight should come off, or how long a cut should run — the surplus side gets ranges and a controlled trial, the deficit side gets a fat floor and nothing else.
With the amount of fat settled, the type becomes the live question — and here the popular narrative and the evidence point in opposite directions. The "seed oil villain" story (canola, soybean, corn, sesame) is not supported by the evidence. Canola oil, often the first oil people name as the bad one, actually has the highest omega-3 proportion among common seed oils and outperforms olive oil on LDL-lowering. Land-animal fats — butter, tallow, lard — show more adverse cardiovascular evidence than seed oils do. A "Mediterranean-keto" hybrid that keeps ketogenic macronutrient ratios but sources fat from plants, nuts, olive oil, and avocado instead of saturated animal fat has only positive literature behind it. (Alan Aragon, "How to Lose Fat & Gain Muscle With Nutrition".)
The same source runs the same reassessment on adjacent villains. Artificial and low-calorie sweeteners are broadly safe at typical consumption levels, and diet beverages are a net-positive weight-loss tool; saccharin is the one sweetener with genuinely adverse evidence, and it is nearly commercially extinct already. Alcohol, by contrast, is a real lever rather than a manufactured one — it causes disinhibited overeating, and removing it saves roughly 1000 calories a day. Roughly 10% of the general population has an alcohol use disorder, frequently masked because drinking is socially normalized.
Underneath all of this sits the heuristic that explains why single-ingredient hunts keep missing: passive overconsumption is driven by refined carbohydrate plus fat, combined with salt and/or sweetness. That combination — hyperpalatability — is the thing doing the work. Which reframes the useful intervention: target the formula, not whichever named ingredient is currently in the dock. It is also a good illustration of the general skepticism Evaluating Evidence & Supplement Quality argues for, applied to food narratives instead of supplement labels.
One fat does have a muscle-specific case. Building on clinical trial evidence that omega-3 fats — from fish, algae, and other sources — support muscle growth and performance, mechanistic studies point to at least three linked mechanisms. The evidence is genuinely preliminary: small samples, often without placebo or control groups.
The researchers behind some of these studies attribute the muscle benefit to reduced inflammation. That explanation is disputed as inconsistent with the broader and decidedly mixed inflammation literature — an instance of the general principle in Evaluating Evidence & Supplement Quality that a study's own account of why it worked should be weighed against corroborating literature rather than accepted with the result.
One dosing caveat matters practically. Most of these mechanistic studies used 2–5 g of omega-3 and lack control groups, while the clinical trial data show effects at lower doses with a consistent minimum around 1.4 g. Mechanistic-study doses should not be read as dosing recommendations. And the picture may not stay purely favorable: omega-3s may raise reactive oxygen species, implicated in cell damage, and cause further subtle mitochondrial changes — the full detail on that was withheld behind a paywall (Physionic Insiders) as of this source, so the chapter genuinely cannot resolve it.
The fat floor established earlier exists because testosterone matters for muscle retention. That makes the supplement aisle's answer to the same problem the natural endpoint of this chapter — and it does not survive contact with the evidence.
A 2020 study analyzed the five best-selling testosterone boosters on Amazon. Three of the five didn't disclose individual ingredient doses at all, hiding behind proprietary blends. Of the ingredients that were disclosed, half had zero positive human studies. Per a tally-based review — with the methodology caveat that counting studies is not weighing them, a point Evaluating Evidence & Supplement Quality develops — saw palmetto and boron each have 2 positive against 6 null studies, and fenugreek has 4 positive against 3 indeterminate. Examine's database concludes the evidence leans against a testosterone increase overall.
Ashwagandha is the most promising ingredient of the bunch, and the scale comparison is the part worth remembering: injected testosterone raised levels by 1740 ng/dL; ashwagandha, at its best, by 96 ng/dL. Despite all this, the top five Amazon test boosters averaged 4.5 out of 5 stars — attributable to placebo effects and to buyers changing their training and diet at the same time and crediting the pill.
The alternatives that do work are unglamorous and mostly already in this chapter: 7–8 hours of sleep, maintaining a healthy body weight, sufficient dietary fat — the floor from Dietary Fat Minimum During a Cut, appearing here as an actual testosterone intervention — and correcting deficiencies in zinc, magnesium, or vitamin D. The application is to skip most OTC test boosters if testosterone is already normal-to-high, and to consider ashwagandha at roughly 600 mg/day mainly for cortisol and stress benefits, with a possible small testosterone bonus, rather than as a primary testosterone strategy. (Jeff Nippard, "The Worst Supplements Everyone Takes For Muscle Growth," 2026.)
This is the same shape as the underdosed and mislabeled muscle-building products catalogued in Evaluating Evidence & Supplement Quality, and as the debunked BCAA category discussed in Protein & Muscle-Building Nutrition. It is also the negative image of the framing applied to supplements that do work: for Creatine Fundamentals and the ergogenics in Resistance Training & Performance Supplements, the correction runs the other way — a real effect that is smaller than the hype, rather than hype with no effect underneath it.